Preeclampsia Clinical Trial
Official title:
Evaluation of Educational Tools Concerning Hypertension in Ambulatory Pregnant Women, Compared With Usual Antenatal Care
Hypertensive disorders of pregnancy happen in 5% of pregnancies. Being aware of symptoms and
complications may help women to present early and preserve their own and their baby's
health.
The proposed research aims to evaluate the impact of educational tools in pregnant women
from an ambulatory population. These tools include a detailed pamphlet (including a
graphic-based summary), a magnet summarizing symptoms and appropriate action, and a video.
Level of knowledge will be evaluated after one month with a validated questionnaire. We will
also evaluate if getting more information about preeclampsia increases patient anxiety as
well as satisfaction about the tools.
Status | Completed |
Enrollment | 247 |
Est. completion date | September 2014 |
Est. primary completion date | September 2014 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Women between 20+0 to 32+6 weeks pregnant - Aged 18 years old or more - Who present at the Blood Sampling in Pregnancy clinic - With an adequate understanding of written and spoken French or English in order to read the pamphlet and fill out the self-administered questionnaire Exclusion Criteria: - Consideration of an interruption of pregnancy for maternal or fetal reasons - Anticipated delivery within the next month. |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
Canada | Centre Hopitalier Universiatire de Sherbrooke | Sherbrooke | Quebec |
Lead Sponsor | Collaborator |
---|---|
Université de Sherbrooke |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Sub-group analysis: age | Diferences in outcomes between control and intervention groups according to group age | 1 month | No |
Other | Sub-group analysis: parity | Differences between control and intervention group according to parity. | 1 month | No |
Other | Sub-group analysis: pre-pregnancy BMI | Differences between control and intervention group according to pre-pregnancy BMI | 1 month | No |
Other | Sub-group analysis: category of health care provider | Differences between control and intervention group according to category of healthcare provider | 1 month | No |
Other | Sub-group analysis: preeclampsia risk factors | Differences between control and intervention group according to preeclampsia risk factors (pre-pregnancy diseases or a history of preeclampsia | 1 month | No |
Other | Sub-group analysis: tobacco use | Differences between control and intervention group according to tobacco use | 1 month | No |
Other | Sub-group analysis: | Differences between control and intervention group according to employment type | 1 month | No |
Other | Sub-group analysis: ethnicity | Differences between control and intervention group according to ethnicity | 1 month | No |
Other | Sub-group analysis: socio-economic level | Differences between control and intervention group according to socio-economic level | 1 month | No |
Other | Sub-group analysis: educational level | Differences between control and intervention group according to educational level | 1 month | No |
Other | Sub-group analysis: marital status | Differences between control and intervention group according to marital status | 1 month | No |
Other | Sub-group analysis:video viewed on site vs. at home | Differences between control and intervention group according to video viewed on-site vs. at home | 1 month | No |
Other | Sub-group analysis:delay since last consultation of the tools | Differences between control and intervention group according to delay since last consultation of the tools. | 1 month | No |
Primary | Knowledge about preeclampsia | Through a questionnaire (7 questions, 35 statements, one global score) | 1 month | No |
Secondary | Anxiety | Question 1: 8 statements (Likert's scale 1 to 6) Question 2 more general | 1 month | Yes |
Secondary | Satisfaction | 3 questions | 1 month | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03510286 -
Validation of a PrCr Dipstick Diagnostic Test in Ghana
|
||
Recruiting |
NCT03313024 -
Berlin-Brandenburg Pregnancy Cohort
|
||
Active, not recruiting |
NCT04990141 -
Molecular Screening Method for Preeclampsia (PREMOM)
|
||
Completed |
NCT02147626 -
Heart Health 4 Moms Trial to Reduce CVD Risk After Preeclampsia
|
N/A | |
Not yet recruiting |
NCT05999851 -
Multiparametric Assessment of Maternal Vascular Function in the Prediction of Hypertensive Disorders of Pregnancy
|
N/A | |
Recruiting |
NCT02923206 -
Proof-of-Concept Trial on Selective Removal of sFlt-1 in Pregnant Women With Preeclampsia Via Apheresis
|
N/A | |
Terminated |
NCT02558023 -
The Treatment of Hypertension Associated With Severe Preeclampsia (PE). A Trial of Urapidil Versus Nicardipine
|
Phase 3 | |
Completed |
NCT02384226 -
User Testing and Feedback for a Mobile Health Program for Postpartum Women: A Pilot Study
|
||
Completed |
NCT02854501 -
Second Trimester Maternal Serum Homocysteine Levels and Uterine Artery Doppler for Prediction of Preeclampsia and Placentation Disorders
|
||
Withdrawn |
NCT05016440 -
Lisinopril for Renal Protection in Postpartum Preeclamptic Women
|
N/A | |
Completed |
NCT02554604 -
Identifying HDL Composition and Function in Preeclamptic and Normal Pregnancies
|
||
Not yet recruiting |
NCT02541110 -
Prediction of Preeclampsia & Other Obstetric Complications by Serum Homocysteine & Doppler
|
N/A | |
Recruiting |
NCT02337049 -
Preeclampsia Subtypes and Surrogate Markers of CVD Risk
|
N/A | |
Recruiting |
NCT02247297 -
Pancreatic Stone Protein (PSP) in Pregnant Women
|
||
Completed |
NCT02238704 -
Cornell University-Micronutrient Initiative Calcium Supplementation Study
|
N/A | |
Withdrawn |
NCT01179542 -
The Involvement of Eukaryotic Translation Initiation Factor 4E (eIF4E) in Human Placental Implantation and in the Pathological Pregnancies: Preeclampsia and IUGR
|
N/A | |
Completed |
NCT01195441 -
Prediction and Prevention of Preeclampsia by First Trimester Ultrasound
|
N/A | |
Completed |
NCT00456118 -
Study of the Role of Tissular Maternofetal Alloimmunization in Placentation Pathologies
|
||
Recruiting |
NCT00117546 -
Cardiovascular and Autonomic Reactivity in Women With a History of Pre-eclampsia
|
Phase 4 | |
Completed |
NCT00787241 -
Platelet Count Trends in Pre-eclamptic Parturients
|
N/A |